Health Condition 1: J452- Mild intermittent asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients between the age group of 18 to 60 years of either sex present with clinical features of Tamaks Shwasa. Recurrent episodes of Wheezing,Breathlessness,Chest tightness and Coughing (particularly at night or in the morning). Mild persistent cases of tamaka shwasa of duration more than 1 month.i.e having night symptoms more than twice per month but less than once a week and FEV1 more than 80% of the predicted value.
Exclusion criteria
Exclusion criteria: Patients below 18 years and above 60 years will be excluded.Tuberculosis (pulmonary).Chronic obstructive pulmonary disease(COPD).Pleural effusion.Cardiac Asthma.Emphysema.Status Asthmaticus.Patients suffering from systemic disorders like renal failure,hypertension,Diabetes Mellitus etc.Pregnancy and lactating monther.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected primary outcome is improvement in the symptoms from tamaka shawsa baseline ( day 0) after 90 days of therapy.Timepoint: 3 month | — |
Secondary
| Measure | Time frame |
|---|---|
| The expected secondary outcome is the safety and efficacy of the therapy under investigation.At the end of the study, safety of drug can be noted with any side effect and four point global assessment scale for efficacy (excellent,good,satisfactory and poor)will be exmined.Timepoint: 3 month | — |
Countries
India
Contacts
Ayurvedic and Unani Tibbia college